- Home
- ONC vs FE Comparison
ONC vs FE Comparison
Compare ONC & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ONC | FE |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | Switzerland | United States |
| Employees | 12000 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 26.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | ONC | FE |
|---|---|---|
| Price | $301.47 | $48.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $385.10 | $51.46 |
| AVG Volume (30 Days) | 301.7K | ★ 3.5M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.80% |
| EPS Growth | N/A | ★ 3.53 |
| EPS | N/A | ★ 0.70 |
| Revenue | N/A | ★ $15,090,000,000.00 |
| Revenue This Year | $723.76 | $4.34 |
| Revenue Next Year | $15.04 | $3.98 |
| P/E Ratio | $614.06 | ★ $68.64 |
| Revenue Growth | N/A | ★ 12.01 |
| 52 Week Low | $249.00 | $40.01 |
| 52 Week High | $385.22 | $52.34 |
Technical Indicators
Market Signals| Indicator | ONC | FE |
|---|---|---|
| Relative Strength Index (RSI) | 60.53 | 56.04 |
| Support Level | $289.57 | $46.09 |
| Resistance Level | $310.50 | $52.01 |
| Average True Range (ATR) | 7.84 | 0.85 |
| MACD | 4.67 | 0.08 |
| Stochastic Oscillator | 73.54 | 69.00 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
About FE FirstEnergy Corp.
FirstEnergy is an investor-owned holding company with operations across five mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.